Cannabis News
No Recreational Cannabis in Costa Rica
Published
12 hours agoon
By
admin
On November 28, 2024, the Costa Rican Constitutional Court, known as Sala IV, made a landmark ruling that has sent shockwaves through the nation and the broader Latin American region: it struck down a proposed referendum aimed at legalizing recreational cannabis. This decision not only halts the immediate efforts to bring recreational cannabis to the ballot but also raises critical questions about the future of cannabis legislation in a country that has seen significant strides in medical marijuana and hemp legislation. This article explores the implications of this ruling, the broader context of cannabis laws in Costa Rica, and what this means for future legislative efforts.
The Constitutional Court’s Ruling
Legal Basis for the Decision
The ruling by Sala IV was grounded in constitutional law and international obligations. The court found that the proposed referendum, which sought to allow Costa Ricans to vote on legalizing recreational cannabis, was unconstitutional based on Article 7 of Costa Rica’s Political Constitution. This article emphasizes that international treaties ratified by Costa Rica take precedence over domestic laws.
The court specifically cited conflicts with several key international agreements:
1. 1961 Single Convention on Narcotic Drugs: This treaty classifies cannabis as a controlled substance and restricts its use to medical and scientific purposes.
2. 1988 UN Convention Against Illicit Traffic in Narcotic Drugs: This agreement reinforces prohibitions against recreational use of drugs, including cannabis.
3. Vienna Convention on Psychotropic Substances: Like the previous treaties, this convention emphasizes restrictions on drug use and trafficking.
The court concluded that any attempt to legalize recreational cannabis through a referendum would violate these international obligations, thus rendering such a measure unconstitutional.
Background of the Proposed Referendum
The initiative for the referendum was led by Erick González Camacho, who sought to gather enough signatures to bring the issue before voters nationwide. The proposal aimed not only to legalize recreational cannabis but also to regulate its production and sale, similar to frameworks established in other countries that have embraced legalization.
The Supreme Electoral Tribunal (TSE) had initially referred González’s request for a referendum to the Constitutional Chamber for review. However, the court’s decision effectively blocks any progress of the bill through both the referendum mechanism and legislative approval without addressing these international conflicts.
The Broader Context of Cannabis Legislation in Costa Rica
While recreational cannabis remains illegal, Costa Rica has made significant strides in legalizing medical marijuana. In 2022, after extensive debate and advocacy from various sectors of society, Costa Rica legalized medical cannabis. This landmark decision allowed patients suffering from various ailments—including chronic pain, epilepsy, and cancer—to access therapeutic products derived from cannabis.
The legalization of medical marijuana marked a significant shift in public policy and social attitudes toward cannabis. It aligned Costa Rica with other Latin American countries that have recognized the medicinal benefits of cannabis while also providing a framework for regulation and oversight.
Moreover, Costa Rica has embraced industrial hemp cultivation as part of its agricultural strategy. The Ministry of Agriculture and Livestock (MAG) has issued numerous licenses for hemp production, signaling a growing acceptance of cannabis-related industries within regulated frameworks. Hemp is seen as a versatile crop with applications ranging from textiles to construction materials.
President Rodrigo Chaves’ Stance
President Rodrigo Chaves has been an outspoken advocate for legalizing recreational cannabis as part of his broader strategy to combat crime and generate tax revenue. Chaves argues that regulating cannabis could provide safe access for consumers while cutting off profits to criminal networks that thrive on illegal drug trade.
In his administration’s view, legalization could also yield significant economic benefits:
-
Tax Revenue: Legalizing recreational cannabis could generate substantial tax revenue that could be reinvested into public services such as healthcare and education.
-
Job Creation: A regulated cannabis market could create jobs across various sectors—from cultivation and retail to distribution and marketing.
-
Tourism: Legalization could attract tourists interested in experiencing a regulated cannabis market similar to those found in countries like Canada and certain U.S. states.
Despite these arguments, public opinion remains divided. Critics express concerns about potential increases in cannabis use among young people and emphasize adherence to international commitments as paramount. The ruling by Sala IV reflects these tensions between progressive policy initiatives and conservative legal frameworks.
Implications of the Court’s Decision
The court’s ruling signifies a substantial setback for advocates seeking to expand cannabis legalization in Costa Rica. It raises critical questions about how future legislation can navigate international obligations while addressing domestic desires for reform. For any new proposals to move forward, they would need to either align with existing treaties or involve a significant shift in Costa Rica’s approach to its international commitments.
In light of this ruling, lawmakers may consider several strategies:
1. Amendment of International Treaties: One potential avenue is advocating for changes at an international level regarding how treaties classify cannabis. However, this is a long-term strategy that would require cooperation from multiple countries.
2. Focus on Medical Cannabis Expansion: Given the court’s acceptance of medical marijuana legislation, advocates may shift their focus toward expanding access to medical products rather than pursuing recreational legalization at this time.
3. Public Education Campaigns: Educating the public about the potential benefits of legalization may help shift public opinion over time, creating an environment more conducive to future legislative efforts.
Public Response and Ongoing Debate
The ruling has reignited discussions around cannabis policy in Costa Rica. Advocates like González remain hopeful for future changes despite this setback; they argue that public sentiment is shifting toward acceptance of recreational use as societal attitudes evolve.
On social media platforms and community forums, citizens are expressing their views—both pro and con—regarding the ruling:
This ongoing debate highlights the complexities surrounding drug policy reform in Costa Rica, a nation known for its progressive social policies yet bound by traditional views on drug use.
The Economic Implications of Cannabis Legislation
While opponents often cite health risks associated with increased drug use as reasons against legalization, proponents highlight several economic benefits:
1. Tax Revenue Generation: Legalizing recreational cannabis could lead to substantial tax revenues that could be allocated toward public services such as education, healthcare, infrastructure development, and drug prevention programs.
2. Job Creation: A regulated market would create numerous jobs across various sectors cultivation, distribution, retail sales and stimulate local economies.
3. Tourism Growth: Countries like Canada have seen increased tourism due to their legalized cannabis markets; Costa Rica could potentially capitalize on this trend by attracting tourists interested in exploring its regulated market.
4. Reduction in Law Enforcement Costs: Legalization may lead to decreased law enforcement costs associated with prosecuting non-violent drug offenses related to possession or use of small amounts of cannabis.
Challenges Facing Economic Arguments
Despite these potential benefits, there are challenges facing advocates who wish to frame legalization as an economic necessity:
-
Concerns Over Public Health: Opponents argue that increased access may lead to higher rates of substance abuse among vulnerable populations.
-
International Obligations: As noted earlier, adherence to international treaties complicates any movement toward legalization; failure to comply could result in diplomatic repercussions or sanctions from other nations or organizations.
The Role of International Treaties
Costa Rica’s obligations under international treaties significantly impact its domestic drug policies:
1. Single Convention on Narcotic Drugs (1961): This treaty aims to combat drug abuse by controlling narcotics through strict regulations; it classifies many substances—including cannabis—as controlled drugs.
2. UN Convention Against Illicit Traffic in Narcotic Drugs (1988): This treaty emphasizes collaboration among nations to combat drug trafficking while reinforcing prohibitions against certain substances’ recreational use.
3. Vienna Convention on Psychotropic Substances (1971): Similar in nature to previous treaties but focuses more specifically on psychotropic substances rather than narcotics alone.
These treaties create a framework within which countries must operate regarding drug policy; thus far, they have largely reinforced prohibitionist approaches globally.
The Need for Reform at an International Level
Advocates for reform argue that existing international treaties are outdated given evolving scientific understandings regarding cannabinoids’ therapeutic properties:
Conclusion
Costa Rica is currently at a pivotal moment in its cannabis legislation following the Constitutional Court’s recent ruling against a proposed referendum for recreational use. This decision highlights the intricate balance between international treaties and domestic reform aspirations, a challenge that many nations face in addressing drug policy. Despite advancements in medical marijuana access and industrial hemp cultivation, the issue of recreational cannabis remains contentious and fraught with legal hurdles. Advocates continue to push for change, fueled by hope that public education campaigns and potential legislative reforms will eventually lead to responsible regulation rather than the historical prohibitionist approaches prevalent in Latin America. Navigating this complex landscape will require lawmakers to engage thoughtfully with constituents, striving to create equitable policies that honor both national interests and international commitments as Costa Rica moves forward into an uncertain yet promising future regarding cannabis use.
COSTA RICA AND CANNABIS, READ ON…
You may like
-
Not Everyone Has A Happy Holiday But Maybe Marijuana Can Help
-
Frosty The SnowMan’s Life Lessons
-
The Best Holiday Whiskey Cocktails
-
Vendors Offering High-Potency Kratom: What You Need to Know
-
PornHub Reveals What People Watched In 2024
-
Ohio adult-use program was only new marijuana market launch in 2024
Cannabis News
Fibromyalgia Patients Enjoy Long Term Benefits After Cannabis Medication Says New Medical Study
Published
2 days agoon
December 16, 2024By
admin
Growing Number Of Studies Back Up Efficacy Of Weed For Fibromyalgia
Fibromyalgia is a chronic condition notorious for being so difficult to treat.
Patients with fibromyalgia struggle with pain throughout the body, particularly affecting the musculoskeletal system. It’s also characterized by other symptoms including sleep and memory issues, fatigue, and mood swings.
Fibromyalgia, being chronic in nature, takes an extremely long time to manage. There is no cure for this disease, but patients are often prescribed a cocktail of medications and are recommended to undergo serious lifestyle changes and therapy sessions to help.
Aside from numerous painkillers, anti-seizure drugs, and antidepressants, fibromyalgia patients greatly benefit from physical therapy, cognitive-behavioral therapy, exercise, and various stress management techniques. While it can be months, or even years, for patients to experience relief, scientists haven’t stopped working to discover better treatment modalities for this condition.
And thankfully, cannabis has shown to be one of them.
Legal marijuana is now giving fibromyalgia patients hope to regain control and quality of their life again. There is a growing number of studies supporting the benefits of weed for fibromyalgia. In one of the latest studies out of London, researchers analyzed the efficacy of cannabis-based medicinal products (CBMPs) which were either oil extracts or flower, on 148 fibromyalgia patients from the UK Medical Cannabis Registry. As is the standard for patients in the United Kingdom who are enrolled in the UK Medical Cannabis Registry, these patients have been unresponsive to traditional medications.
Yet, after being treated with cannabis, the patients reported improvements at various intervals, namely 1, 3, and 6 months after. “Improvements in the generalized anxiety disorder-7 questionnaire, single-item sleep quality scale, fibromyalgia symptom severity score and EQ-5D-5L Index values were observed at each follow up period compared to baseline,” said the researchers. They added that the participants reported significant reductions in their dependence of prescription opioids during the time of the study. However, they did experience dry mouth, headache, and some fatigue.
“Positive associations between initiation of CBMP therapy and decreased fibromyalgia severity were observed at all time points…” concluded the authors. “These findings are complemented by wider literature,” they wrote.
Meanwhile, another recent study from Colombia analyzed how various cannabis preparations impacted the symptoms of patients with fibromyalgia syndrome, also known as FMS. To achieve this, an international team of researchers pored through data taken from 14 clinical studies as well as 5 review papers. According to their findings, cannabis products were effective in reducing pain and other symptoms, while keeping side effects to a minimum.
They concluded that cannabis products “can improve musculoskeletal, somatic, and psychiatric symptoms in patients with FMS, mainly pain, fatigue, and depression; also, these products could be considered as safe,” they wrote.
Another study from 2022 found that cannabis was effective, especially in helping women who were suffering from treatment-resistant fibromyalgia. For this study, researchers utilized the World Health Organization Quality of Life Bref questionnaire to gauge the quality of life of 30 female fibromyalgia patients, whose ages ranged from 18 to 70 years.
Given they were all treatment-resistant cases, they already exhausted all conventional pharmacological fibromyalgia treatment. The questionnaire focused on four aspects: psychological health, social relationships, environment, and physical health. The women were asked to fill up the questionnaire before medicating with cannabis, then again a month after. They were asked to choose their preferred way to medicate: whether they ingest, smoke, or vaporize, it was up to them.
During follow-up sessions, the researchers found that the treatment contributed to an improvement in general quality of life, activities of daily living, general health, psychological health, physical health, pain and discomfort. Th patients also reported seeing positive changes that affected aspects of fatigue, pain, self-esteem, memory, and positive feelings as a whole.
Conclusion
It’s no surprise there’s a growing interest in using cannabis for fibromyalgia. Cannabis works so well for this condition because of the way it interacts with the endocannabinoid system. After all, the human endocannabinoid system is responsible for regulating pain as well as so many other important functions in the body.
Since pain is a hallmark symptom of fibromyalgia, patients who medicate with marijuana find tremendous relief. Even better, many cannabis medications such as edibles provide long-lasting pain relief without the addictive and harmful effects of opioids and other conventional medications. In addition, the pain caused by fibromyalgia can make it difficult to sleep and rest well. Cannabis also has a multitude of other benefits for fibromyalgia patients, including its ability to fight inflammation, regulate moods, and improve sleep.
There’s a great variety of weed products in the market that can help alleviate pain and reduce symptoms. From edibles to oils and tinctures, there’s a medication out there for everyone. Edibles are preferred for pain patients in general, because it provides longer-lasting relief from many different types of pain. However, capsules and tinctures allow patients to enjoy more control over dosing. When it comes to choosing whether to take CBD or THC, many patients find relief when consuming a product with a combination of both cannabinoids. Excessively high THC may not be suitable for older patients or those that need to focus, so getting one with a good balance of both or is CBD dominant may be ideal.
Speak to your doctor if you’d like to include cannabis therapies to target fibromyalgia symptoms. Healthcare providers with experience in marijuana medication can also provide valuable advice.
WHAT THC CAN DO FOR FIBROMYAGIA, READ ON…
WHAT DOES THC DO FOR FIBRYOMYAGLIA PATIENTS? READ THIS!
Cannabis News
Why Does Elton John, Time Magazine’s Icon of the Year, Think Marijuana Legalization is a Terrible Idea?
Published
2 days agoon
December 15, 2024By
admin
Sir Elton John, a music legend and cultural icon recently honored as TIME Magazine’s “Icon of the Year,” has once again made headlines—not for his music, but for his polarizing stance on cannabis legalization. While many public figures and celebrities have championed the move toward legalizing cannabis, Elton John has called it “the greatest mistake of all time.” His bold statement has ignited fierce debate across social media and within both cannabis advocacy and public health circles.
So, what’s behind Elton’s strong disapproval of cannabis legalization? And what does it mean for the ongoing conversation about the future of cannabis laws worldwide?
Elton John’s Journey and the Role of Addiction
Elton John’s opinion on cannabis legalization is deeply rooted in his personal journey with addiction. The singer has been candid about his struggles with substance abuse in the past, often describing his recovery as a life-saving transformation. Having celebrated over 30 years of sobriety, Elton frequently uses his platform to promote awareness about the dangers of substance dependency.
“I’ve seen firsthand what addiction can do—not just to individuals but to their families and communities,” he shared during a recent interview. For Elton, cannabis represents not just a plant, but a potential gateway to dependency—a perspective often echoed by critics of legalization. While it’s true that cannabis is less addictive than substances like opioids or alcohol, Elton’s concerns resonate with those who argue that legalization could normalize use, particularly among younger populations.
The Celebrity Divide: Advocates vs. Skeptics
Elton John’s stance is especially striking because it contrasts sharply with the views of many of his peers in the entertainment industry. Celebrities like Snoop Dogg, Seth Rogen, and Miley Cyrus have been vocal proponents of cannabis legalization, often highlighting its potential to generate tax revenue, reduce incarceration rates, and provide medical benefits.
But Elton isn’t alone in his skepticism. Figures like Dr. Drew Pinsky and even some policymakers have raised concerns about the unintended consequences of legalization, from increases in impaired driving to the potential health risks of high-potency cannabis products.
The celebrity divide on cannabis reflects a broader societal debate: while many celebrate the economic and medicinal opportunities presented by legalization, others remain wary of its long-term implications.
The Economic Boom vs. Public Health Concerns
Legalizing cannabis has undeniably created a booming industry. In the United States alone, the legal cannabis market is projected to reach $43 billion by 2025. States like Colorado and California have reported substantial tax revenues, which have been reinvested into education, infrastructure, and public health programs.
But critics, including Elton John, caution against focusing solely on the economic benefits. “Money doesn’t justify the damage this could cause,” he argued. Public health experts have raised concerns about the potential for increased cannabis use among adolescents, as well as the risks associated with long-term consumption, such as memory impairment and dependency. Elton’s criticism taps into these anxieties. He worries that the widespread availability of cannabis could lead to a cultural shift where drug use becomes overly normalized, overshadowing the substance’s potential risks.
Cannabis in the Spotlight: Public Perception and Policy
Elton John’s comments also come at a time when cannabis legalization is at the forefront of global policy discussions. Countries like Canada and Uruguay have fully legalized the drug, while others, including Germany and Mexico, are considering similar measures. In the U.S., over 20 states have embraced recreational cannabis, with many more allowing it for medicinal purposes.
Supporters of legalization argue that these policies reduce the burden on the criminal justice system and help dismantle the illicit drug trade. However, opponents like Elton worry that such measures send the wrong message, particularly to younger generations.
Studies suggest that public perception of cannabis has shifted significantly over the past few decades. According to a recent Gallup poll, 68% of Americans now support legalization—a stark contrast to the early 2000s, when support hovered around 30%. This growing acceptance reflects changing societal attitudes but also underscores the challenges of addressing potential downsides.
Is Elton John Out of Touch or Raising a Valid Concern?
Unsurprisingly, Elton John’s comments have sparked a firestorm on social media. Some users praised his courage for speaking out against a popular trend, while others accused him of being out of touch with modern science and policy.
Advocates for legalization argue that regulated markets are far safer than prohibition, which often fuels black-market activity and associated violence. They also point to the plant’s proven medicinal benefits, from alleviating chronic pain to reducing seizures in epilepsy patients. However, Elton’s defenders argue that his perspective is a reminder to proceed with caution. “It’s not about banning cannabis altogether,” one user wrote. “It’s about acknowledging the risks and ensuring we don’t glamorize it.”
What Comes Next?
As cannabis continues to gain legal and cultural acceptance, the debate surrounding its impact will only intensify. Elton John’s comments serve as a reminder that even as we celebrate progress, we must remain vigilant about the potential downsides.
For cannabis advocates, the challenge lies in addressing concerns like those raised by Elton without derailing the broader momentum for reform. This could mean implementing stricter regulations around marketing and sales, funding more public health research, and investing in education campaigns to ensure informed consumption.
For critics, Elton’s remarks underscore the importance of considering the long-term societal impacts of legalization. As he put it, “We can’t afford to make mistakes when it comes to something that affects so many lives.”
A Call for Balanced Dialogue
Elton John’s critique of cannabis legalization might not win him fans in the cannabis community, but it has succeeded in reigniting an important conversation
WHAT DO PEOPLE WANT, LEGALIZION OR NOT, READ ON…
Cannabis News
How to Deal with a Bad Trip or Greening Out According to a New Science and Medical Report
Published
4 days agoon
December 14, 2024By
admin
How to Deal with a Bad Trip According to Science
After more than two decades of psychedelic exploration, I’ve learned that the term “bad trip” is something of a misnomer. Sure, I’ve had my share of experiences where reality seemed to fold in on itself like a cosmic origami gone wrong, where my thoughts spiraled into places that would make Edgar Allan Poe uncomfortable. But here’s the thing – these supposedly “bad” trips often turned out to be the most transformative.
Think of it like psychological weight training. Just as you can’t build muscle without resistance, sometimes you need those challenging psychedelic experiences to strengthen your mental fortitude. The problem isn’t necessarily the intensity of the experience, but rather our interpretation and response to it.
I’ve watched countless people “lose their shit” during overwhelming psychedelic experiences. Their minds become like runaway trains, picking up speed as they careen toward what feels like certain doom. But here’s what two decades of psychonautic adventures have taught me: there’s no such thing as a bad trip, only challenging experiences that we’re not yet equipped to handle.
Recently, researchers decided to take a scientific look at how people navigate these turbulent psychedelic waters. They gathered data from hundreds of psychedelic experiences, analyzing the various coping mechanisms people employ when things get weird. And boy, do things get weird.
Today, we’re going to dive into their findings, examining four main strategies that people use to stay afloat when the psychedelic seas get rough. I’ll also share some personal insights – tricks and techniques I’ve learned from countless hours of surfing the waves of altered consciousness.
So whether you’re an experienced psychonaut or simply curious about how to handle intense psychological experiences, buckle up. We’re about to explore the art and science of turning psychological chaos into catalysts for growth. Let’s dive in.
Here’s a 500-word segment on “A Closer Look at the Study”:
A Closer Look at the Study
The research, published in Scientific Reports, combined two fascinating studies. The first examined 16 participants who attended psychedelic retreats in the Netherlands and Mexico, while the second analyzed survey data from 869 people, with roughly two-thirds reporting challenging experiences during their psychedelic journeys.
What they discovered was both illuminating and validating for many psychonauts. The researchers identified four main themes in how people cope with challenging experiences. First, there’s what they called “Inner Responses” – think meditation, self-talk, and making meaning from the chaos. Then there’s “Embodied Practice and Environment Engagement” – basically, using breathing techniques, movement, and connecting with your surroundings to ground yourself. The third theme involved “Interpersonal Responses,” where some folks sought social support while others preferred solitude. Finally, “Facilitator Responses” highlighted the crucial role of guides and therapists in providing support during difficult moments.
The researchers emphasized that there’s no one-size-fits-all approach to managing challenging psychedelic experiences. As they noted, “Therapists should be well-versed in a broad spectrum of response strategies and recognize that different strategies may be more or less effective for different individuals.” This nuanced understanding is crucial for the emerging field of psychedelic-assisted therapy.
Here’s where things get interesting – and frankly, a bit infuriating. We’re at a point where prestigious research institutions are publishing detailed studies about implementing psychedelic therapy, yet these substances remain Schedule I under the Controlled Substances Act. According to this antiquated classification, these compounds have “no accepted medical use” and a “high potential for abuse.”
Let that sink in for a moment. We have researchers from University College London meticulously documenting how to optimize therapeutic outcomes with these substances, while simultaneously, our government maintains they have no medical value. The cognitive dissonance is staggering.
And it’s not just this study. There’s a growing mountain of evidence supporting the therapeutic potential of psychedelics for conditions ranging from PTSD to depression to end-of-life anxiety. Yet the CSA continues to block access to these potentially life-changing treatments.
You know what really grinds my gears? This isn’t just about maintaining outdated laws – it’s about actively denying people access to healing. The War on Drugs isn’t just a war on substances; it’s a war on alternative approaches to mental health and personal growth. Every day that these substances remain Schedule I is another day that countless individuals are denied potentially transformative treatments.
When I see studies like this – serious, methodical research into maximizing the therapeutic benefits of psychedelics – I can’t help but think about all the people suffering needlessly because of prohibition. The CSA isn’t protecting public health; it’s protecting the status quo at the expense of human wellbeing. In my view, that’s not just misguided – it’s morally indefensible.
You know what’s funny? In over two decades of psychedelic exploration, I’ve never really had what you’d call a “bad trip.” The closest I’ve come to death-defying psychological horror was actually from alcohol, but that’s a whole different demon we won’t summon today.
The truth is, avoiding nightmarish psychedelic experiences isn’t rocket science. It’s more like gardening – prepare the soil (your mind), choose the right environment (your setting), and respect the natural process. Let me break down my tried-and-true principles for maintaining sanity when reality decides to do backflips.
First up: Set and Setting. This isn’t just some hippie mantra – it’s the foundation of any meaningful psychedelic experience. Your mindset going in is like packing for a trip. If you’re carrying emotional baggage – relationship drama, work stress, existential crisis – expect those bags to get thoroughly unpacked during your journey. That’s not necessarily bad, but you better be ready to sort through that emotional luggage.
And setting? That’s your launch pad. You need a space where you feel safe enough to completely lose your shit if necessary. Trusted friends, comfortable environment, no unexpected visitors or responsibilities. I could write a whole book about setting alone, but let’s just say: if you wouldn’t feel comfortable having an emotional breakdown there, it’s not the right place for a psychedelic journey.
Here’s another golden rule: Accept that you’re not in control. The sooner you surrender to this truth, the smoother your journey will be. Psychedelics are going to do what they do, and your ego’s attempts to steer the ship will only lead to mutiny. I’ve seen too many self-proclaimed “psychedelic masters” get humbled when they try to control the uncontrollable. Stay humble, accept whatever comes, and remember – you signed up for this ride.
When things get intense (and they will), remember the power of breath. Find a quiet, preferably dark space, put on some gentle tunes, and breathe. Eight counts in, eight counts out. Simple as that. It’s remarkable how controlling your breath can ground you when reality seems to be melting. I call this the psychedelic panic button – it works every time.
Finally, remember this fundamental truth: what goes up must come down. Whether your trip lasts 16 hours or three days (yes, I’ve been there), eventually you’ll return to baseline. If you’re feeling stuck in the trip after the substance should have worn off, that’s all mental. Understanding this can be incredibly reassuring when you’re convinced you’ll be seeing fractals forever.
These principles have kept me grounded through countless psychedelic adventures. They’re like having a cosmic safety net – they won’t prevent intense experiences, but they’ll help you navigate them with grace. Remember, psychedelics aren’t about avoiding challenges; they’re about facing them with wisdom and courage.
After decades of exploring the psychedelic realms, I’ve come to understand these substances as powerful tools for healing collective trauma and expanding human consciousness. While they’re certainly not for everyone – and I’d never suggest they are – their potential for facilitating profound personal transformation is undeniable.
The current push to medicalize psychedelics is a step in the right direction, but it shouldn’t be the only path forward. Restricting these substances to clinical settings would be like limiting music to therapy sessions – sure, music has therapeutic value, but its power extends far beyond the therapist’s office.
Some of my most transformative experiences happened far from any clinical setting. I remember one particularly profound journey in the mountains of Oaxaca, 3,000 meters above sea level. After two hours in a traditional Mayan Temascal (sweat lodge), purging in pitch darkness, I spent six hours witnessing impossible fractals dancing across ancient rocks. In that space, I experienced a truth that no amount of talk therapy could have revealed: that separation is merely an illusion, and we’re all part of one cosmic soup, atoms dancing to the universe’s eternal rhythm.
You can’t schedule that kind of revelation for a 50-minute session.
This is why I advocate for broader access to these sacred tools. Yes, they have immense therapeutic potential, but they’re also catalysts for spiritual growth, philosophical insight, and cultural evolution. When used responsibly and with proper respect, psychedelics can help us understand ourselves and our place in the universe in ways that conventional methods simply can’t match.
The emerging science around managing challenging psychedelic experiences is valuable, but it’s just one piece of a much larger puzzle. These substances have been teaching and healing humans for millennia, long before we had clinical trials or peer-reviewed papers. As we move forward with psychedelic research and therapy, let’s not forget that sometimes the most profound healing happens not in a sterile clinic, but on a mountain top, face-to-face with the infinite.
HOW TO DEAL WITH A BAD TRIP, READ ON..
Not Everyone Has A Happy Holiday But Maybe Marijuana Can Help
Frosty The SnowMan’s Life Lessons
The Best Holiday Whiskey Cocktails
Vendors Offering High-Potency Kratom: What You Need to Know
PornHub Reveals What People Watched In 2024
No Recreational Cannabis in Costa Rica
Ohio adult-use program was only new marijuana market launch in 2024
Politico Article: New Jersey – CRC approves social equity tax increase It is far lower than what was considered
Fibromyalgia Patients Enjoy Long Term Benefits After Cannabis Medication Says New Medical Study
Why Does Elton John, Time Magazine’s Icon of the Year, Think Marijuana Legalization is a Terrible Idea?
Distressed Cannabis Business Takeaways – Canna Law Blog™
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
What you Need to Know
Drug Testing for Marijuana – The Joint Blog
NCIA Write About Their Equity Scholarship Program
It has been a wild news week – here’s how CBD and weed can help you relax
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
A new April 20 cannabis contest includes a $40,000 purse
Your Go-To Source for Cannabis Logos and Designs
UArizona launches online cannabis compliance online course
Trending
-
Cannabis News2 years ago
Distressed Cannabis Business Takeaways – Canna Law Blog™
-
One-Hit Wonders2 years ago
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
-
Cannabis 1012 years ago
What you Need to Know
-
drug testing12 months ago
Drug Testing for Marijuana – The Joint Blog
-
Education2 years ago
NCIA Write About Their Equity Scholarship Program
-
Cannabis2 years ago
It has been a wild news week – here’s how CBD and weed can help you relax
-
Marijuana Business Daily2 years ago
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
-
California2 years ago
A new April 20 cannabis contest includes a $40,000 purse